- Home
- TECH vs CHE Comparison
TECH vs CHE Comparison
Compare TECH & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CHE
- Stock Information
- Founded
- TECH 1976
- CHE 1970
- Country
- TECH United States
- CHE United States
- Employees
- TECH N/A
- CHE N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CHE Medical/Nursing Services
- Sector
- TECH Health Care
- CHE Health Care
- Exchange
- TECH Nasdaq
- CHE Nasdaq
- Market Cap
- TECH 7.8B
- CHE 8.8B
- IPO Year
- TECH 1989
- CHE N/A
- Fundamental
- Price
- TECH $49.15
- CHE $579.58
- Analyst Decision
- TECH Buy
- CHE Buy
- Analyst Count
- TECH 10
- CHE 1
- Target Price
- TECH $73.44
- CHE $674.00
- AVG Volume (30 Days)
- TECH 2.3M
- CHE 135.6K
- Earning Date
- TECH 05-07-2025
- CHE 04-23-2025
- Dividend Yield
- TECH 0.65%
- CHE 0.34%
- EPS Growth
- TECH N/A
- CHE 10.48
- EPS
- TECH 0.83
- CHE 20.53
- Revenue
- TECH $1,208,770,000.00
- CHE $2,488,997,000.00
- Revenue This Year
- TECH $8.19
- CHE $9.53
- Revenue Next Year
- TECH $8.61
- CHE $6.08
- P/E Ratio
- TECH $59.07
- CHE $28.25
- Revenue Growth
- TECH 4.72
- CHE 8.52
- 52 Week Low
- TECH $46.44
- CHE $512.12
- 52 Week High
- TECH $85.57
- CHE $623.61
- Technical
- Relative Strength Index (RSI)
- TECH 44.74
- CHE 52.46
- Support Level
- TECH $46.35
- CHE $550.47
- Resistance Level
- TECH $54.40
- CHE $575.41
- Average True Range (ATR)
- TECH 2.17
- CHE 11.73
- MACD
- TECH 0.27
- CHE 0.49
- Stochastic Oscillator
- TECH 34.78
- CHE 88.48
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.